2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $301M | $319M | $314M | $344M | $378M |
Cost of Revenue | $193M | $209M | $221M | $244M | $234M |
Gross Profit | $108M | $109M | $92M | $101M | $145M |
Gross Profit % | 36% | 34% | 29% | 29% | 38% |
R&D Expenses | $5.7M | $7.7M | $7M | $6.2M | $6.9M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | -$14M | -$39M | -$49M | -$39M | -$6.1M |
Dep. & Amort. | $4.9M | $4.1M | $2.8M | $2.7M | $9.3M |
Def. Tax | $0 | $0 | $0 | $0 | $0 |
Stock Comp. | $7.9M | $17M | $15M | $16M | $16M |
Chg. in WC | -$11M | -$21M | -$51M | $34M | -$18M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $29M | $51M | $9.5M | $33M | $75M |
ST Investments | $34M | $42M | $5.7M | $0 | $0 |
Cash & ST Inv. | $64M | $93M | $15M | $33M | $75M |
Receivables | $23M | $32M | $42M | $43M | $43M |
Inventory | $77M | $76M | $116M | $73M | $85M |
HNST delivered strong Q1 results with revenue of $97M (up 13% YoY), gross margin expansion to 39% (up 170 bps), positive net income of $3M, and adjusted EBITDA margin of 7% (sixth consecutive quarter of positive adjusted EBITDA).
The company reaffirmed its full-year 2025 financial outlook: net revenue growth of 4%-6% YoY and adjusted EBITDA in the range of $27M-$30M, including the impact of newly announced tariffs.
Growth was driven by strong performance in wipes (over 40% consumption growth) and baby personal care, with household penetration rising to 7.3% and repeat usage up over 200 bps; however, diaper sales faced headwinds due to distribution changes at a key retailer (Target) and category softness.
HNST is actively managing tariff headwinds with a three-pronged mitigation strategy (agile planning, inventory management, supplier collaboration), expecting a 1.5 percentage point net impact on gross margin in 2025, which will be offset by cost savings and efficiencies.
The company continues to invest in brand building and innovation, with increased marketing spend (13% of revenue in Q1), ongoing distribution expansion (notably in grocery/drug channels and online), and the launch of an improved diaper product; balance sheet remains strong with $73M in cash and no debt.